Unique ID issued by UMIN | UMIN000009664 |
---|---|
Receipt number | R000011238 |
Scientific Title | The Predictive Factors for Refractory Status and Readmission after Tacrolimus Treatment in Patients with Active Ulcerative Colitis |
Date of disclosure of the study information | 2012/12/29 |
Last modified on | 2014/07/08 19:48:23 |
The Predictive Factors for Refractory Status and Readmission after Tacrolimus Treatment in Patients with Active Ulcerative Colitis
The Predictive Factors for Refractory Status and Readmission after Tacrolimus Treatment in Patients with Active Ulcerative Colitis
The Predictive Factors for Refractory Status and Readmission after Tacrolimus Treatment in Patients with Active Ulcerative Colitis
The Predictive Factors for Refractory Status and Readmission after Tacrolimus Treatment in Patients with Active Ulcerative Colitis
Japan |
Ulcerative Colitis
Gastroenterology |
Others
NO
The aim of the present study is to investigate the predictors for refractory to Tacrolimus and readmission after Tacrolimus therapy in patients with active UC.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
The predictors for refractory to Tacrolimus
The predictors for readmission after Tacrolimus therapy
*Refractory tacrolimus is defined a patient who underwent surgery or changed to alternative treatment during TAC therapy with high trough level (10-15ng/ml, at least 7 days)
*Relapse is defined as UC-related readmission within 6 months after Tacrolimus therapy
1.The cumulative colectomy-free survival over 6 months
2.Duration of maintaining as the state of non-relapsing*
*State of non-relapse is defined by Lichtiger's clinical activity index (CAI) score: Total score<=3
3.State of mucosal healing defined by elements of endoscopic findings in Mayo score
4.Ratio of patients who can achieve steroid withdrawal and the duration for steroid withdrawal
5.Decrease of concentration of C-reactive protein as an inflammatory marker
6.Overall safety during maintenance therpy
Observational
20 | years-old | <= |
65 | years-old | > |
Male and Female
Inclusion criteria
Patients who meets all criteria 1 and 2.
1. Patients with moderate to severe active disease
Lichtiger's clinical activity index (CAI) >= 9
2.Eligible patients were aged 20 to 65 years old
Exclusion criteria
1.Patients with serious infectious disease
2.Patients with serious heart disease
3.Patients with serious kidney disease
4.Patients with serious liver disease
5.Patients with diabetes
6.Patients who are pregnant or have the possibility of pregnancy
7.Patients with malignancy
8.Patients who had adverse effect and/or high risk in administration thiopurine
9.Patients who judged as "non-eligible" for this study by responsible doctors
60
1st name | |
Middle name | |
Last name | Nakamura Shiro |
Hyogo College of Medicine
Internal Medicine, Lower Gastroenterology
663-8501 1-1 Mukogawa-cho Nishinomiya-city Hyogo
0798-45-6662
shiro@hyo-med.ac.jp
1st name | |
Middle name | |
Last name | Yoko Yokoyama |
Hyogo College of Medicine
Internal Medicine, Lower Gastroenterology
663-8501 1-1 Mukogawa-cho Nishinomiya-city Hyogo
0798-45-6662
yoko0502@hyo-med.ac.jp
Internal Medicine, Lower Gastroenterology
Hyogo College of Medicine, Internal Medicine, Lower Gastroenterology
Other
NO
兵庫医科大学 内科学 下部消化管科
2012 | Year | 12 | Month | 29 | Day |
Unpublished
Enrolling by invitation
2009 | Year | 12 | Month | 01 | Day |
2009 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
None
2012 | Year | 12 | Month | 29 | Day |
2014 | Year | 07 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011238